Ying Liu
@YingLiu88
Followers
313
Following
107
Statuses
105
GYN MedOnc and Clinical Genetics MSKCC | Columbia Residency | DukeMed | fighting health disparities | #tarheel for life! | opinions my own
New York, NY
Joined February 2015
RT @OncoAlert: The LIGHT study (NCT02983799) evaluated olaparib in patients with platinum-sensitive relapsed #OvarianCancer , categorized b…
0
16
0
I’m incredibly excited about GY036, the first pragmatic and streamlined clinical trial out of @NRGonc. Please spread the word and enroll patients! @TeamOvary_MSK @MSK_DeptOfMed @MSKCancerCenter
NRG-GY036 activation: A Phase III Trial of One vs. Two Years of Maintenance Olaparib, with or Without Bevacizumab, in Patients with BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum-Based Chemotherapy
1
4
27
RT @tsialater: Check out our new article "Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor…
0
8
0
Gestational trophoblastic neoplasm: Patient outcomes and clinical pear... Finally out thanks to @AaronPraissMD! @TeamEndo_MSK @MSKCancerCenter @MSK_DeptOfMed
0
1
9
That’s a wrap on a wonderful #CGAIGC24! So great to have a big @MSKCancerCenter presence, especially our amazing #geneticcounselors @AliciaLatham10 @abbassmohd @YoninaMG @CGAIGC @StadlerZsofia @meghar111
4
2
22
So proud of EliseFiala and our poster of distinction on differences in melanoma prevalence by ancestry and implications for family history of melanoma in Non-White patients when considering testing for CDKN2A @CGAIGC @MSKCancerCenter @MSK_DeptOfMed #CGAIGC24
0
0
5
Always happy to see a GYN case from our amazing GCs highlighted @CGAIGC, especially one that shows the heterogeneity in LS with uterine carcinosarcoma and a mixed MSH-H and POLE phenotype!@TeamEndo_MSK @MSKCancerCenter @MSK_DeptOfMed
0
2
12
How fitting that @CGAIGC picked two posters highlighting this MSH6 R1076C hypomorphic variant with potentially lower endometrial cancer risk. Power of combining big epi data with more granular tumor-normal data to answer this question. More to come from our GCs! @TeamEndo_MSK
0
2
10
@meghar111 and Victoria Groner reporting important rare biallelic NTHL1 cases. This highlights the importance of these n of 1 cases and sharing data! @CGAIGC #CGAIGC24 @MSK_DeptOfMed @MSKCancerCenter
0
1
7
The @MSKCancerCenter experience with #CTNNA1 described by @meghar111, which includes gastric tumors and LCIS @CGAIGC #CGAIGC24
0
1
12
Jeopardy…the best part of #CGAIGC24!! Go Mismatch Mavericks and @AliciaLatham10!! Shout out to our awesome GC artists and their signs. @meghar111 @CGAIGC @MSKCancerCenter @MSK_DeptOfMed
0
3
7
We are lucky to have a colorectal surgeon like @abbassmohd @MSKCancerCenter who understands the importance of genetic testing and implications of results on surgical decision making in #lynchsyndrome #CGAIGC24
0
3
18
Great to see more GYN content during #CGAIGC24 and thanks for your work for GYN cancers on NCCN! We need more data on OC in Lynch to provide personalized approach to risk reduction. @TeamEndo_MSK @TeamOvary_MSK
Dr. Lee-May Chen kicking off our Friday session with a talk on gynecological controversies in Lynch Syndrome #cgaigc24
0
1
7
Great first #CGAIGC24 and GC Awareness Day! @AliciaLatham10 and #kelseybreen representing @MSK_DeptOfMed and @MSKCancerCenter by presenting their experiences with GI cancers in patients with #Li-Fraumeni
0
0
6
RT @CGAIGC: Since it's still #GeneticCounselorAwarenessDay @AparajitaSingh0 also spoke to @meghar111 a genetic counselor from @MSKCancerCen…
0
3
0
Great talk!! Shows the power of MSK-IMPACT to pair tumor and normal sequencing to allow these types of studies. @MSKCancerCenter @MSK_DeptOfMed #CGAIGC24
Matteo Repetto from @MSKCancerCenter presented on patients with MUTYH germline variants who developed cancer and the prevalence of subsequent somatic mutations.
0
1
10
Congrats @saramoufarrij1 and @TeamEndo_MSK for this awesome work! Concurrent POLE hotspot mutations and mismatch repair deficiency/micro...
0
1
3
RT @CGAIGC: 📢Learn more about @MSKCME's two-day symposium on clinical #cancergenetics. Experts specializing in disease-specific managemen…
0
12
0
My amazing mentor #CarolAghajanian talking about streamlining clinical trials. Excited to implement these tips into NRG GY036 to pragmatically look at PARPi maintenance de-escalation in #ovariancancer @NRGonc @MSKCancerCenter @MSK_DeptOfMed
0
5
18
RT @MSKCME: Join us for a comprehensive update on clinical #cancergenetics w/ leading experts from @MSKCancerCenter. We'll explore the late…
0
9
0